Safeguard Scientifics, Inc. · OTC:SFES
Safeguard Scientifics — Merger or Acquisition (June 2004)
16 slides from Safeguard Scientifics's merger presentation, Jun 1, 2004

Slide 1: Conference Call: Agreement to Sell CompuCom Systems, Inc.
Safeguard Scientifics, Inc. Conference Call June 1, 2004 Agreement to Sell CompuCom Systems, Inc.

Slide 2: Forward Looking Statements
Except for the historical information and discussions contained herein, statements contained in this presentation may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertaint

Slide 3: Additional Information & Where to Find It
In connection with the previously-announced CompuCom Systems, Inc. merger, both CompuCom and Safeguard will be filing proxy statements and other relevant documents with the Securities and Exchange Commission (SEC). STOCKHOLDERS OF COMPUCOM AND SAFEGUARD ARE URGED TO READ THEIR RESPECTIVE PROXY STATE

Slide 4: Agenda
Agenda Why support a sale of CompuCom? Background Description of Transaction Use of Proceeds Effect of Transaction Current Strategic Companies 4

Slide 5: Background
Initial investment in CompuCom: 1984 Investment to date: $67 million 51% equity interest (58% voting interest) IPO in 1985 (NASDAQ: CMPC) $1.5 billion revenues (2003) Background 6

Slide 6: Background: Strategic vs. Non-Strategic Companies
Background Strategic vs. Non-Strategic Companies Ownership: Generally majority or greater Funds needed to continue CMPC growth CMPC elected to seek buyer Platinum Equity, LLC 7

Slide 7: Description of Transaction
All cash $4.60 per common share $15 million for preferred shares Total gross proceeds = $128 million* SFE will post $6.3 million letter of credit to secure certain lease obligations * Excludes estimated transaction costs of approximately $1 million Description of Transaction 8

Slide 8: Conditions to Closing
Safeguard shareholder approval CompuCom shareholder approval Buyer obtains financing for portion of purchase price Regulatory approval Conditions to Closing 9

Slide 9: Use of Proceeds
$128 million cash in gross proceeds Increase ownership in Strategic Companies Fund growth of Strategic Companies Acquire new Strategic Companies Modify Safeguard's capital structure: * Retire 5% Convertible Sub. Notes due 2006 * Escrow interest due on 2024 Notes thru 3/09 Increase Safeguard's cash b

Slide 10: Effect of Transaction - Accounting
Effect of Transaction - Accounting 11 Carrying value CMPC $147.5 million (3/2004) Impairment Charge 2Q'04 * CMPC results presented as discontinued operations as of closing Tax: $61 million gain on sale to be offset by capital loss carryforwards * Subject to change based on several factors, including

Slide 11: 2003 YTD Financial Results - Pro-Forma
2003 YTD Financial Results - Pro-Forma ($ in millions) 12

Slide 12: Q1 2004 Financial Results - Pro-Forma
Q1 2004 Financial Results - Pro-Forma ($ in millions) 13

Slide 13: 3/31/04 Balance Sheets - Pro-Forma
3/31/04 Balance Sheets - Pro-Forma ($ in millions) 14

Slide 14: Post Transaction Safeguard Scientifics, Inc.
Post Transaction Safeguard Scientifics, Inc. Strategic Companies Non-Strategic Companies Time-to-Volume Stage Viable Product/Service Capable of Rapid Growth Business Decision Solutions Healthcare Life Sciences Safeguard Majority Ownership Generally Minority Interest Not Within SFE Strategic Focus Pr

Slide 15: Current Strategic Companies
Strategic Company Vertical Markets Served Alliance Consulting Pharma / Life Sciences (100%) Financial Services Manufacturing, Retail & Distribution Mantas Financial Services & (84%) Telecommunications ChromaVision Healthcare / Pharma (57%) Current Strategic Companies 16

Slide 16: Q & A
Safeguard Scientifics, Inc. Conference Call June 1, 2004 Q & A
Source: SEC EDGAR · DEFA14A filed Jun 1, 2004




